{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:29:21Z","timestamp":1765960161490,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.mayocpiqo.2021.02.002","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T22:00:19Z","timestamp":1615759219000},"page":"442-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association Between Chronic Statin Use and 30-Day Mortality in Hospitalized Patients With COVID-19"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2098-2868","authenticated-orcid":false,"given":"Zachary A.","family":"Yetmar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-9639","authenticated-orcid":false,"given":"Douglas W.","family":"Challener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imad M.","family":"Tleyjeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Rizwan","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7796-7680","authenticated-orcid":false,"given":"Andrew D.","family":"Badley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0880-4498","authenticated-orcid":false,"given":"John C.","family":"O\u2019Horo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mayocpiqo.2021.02.002_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.mayocp.2020.02.003","article-title":"Guide to understanding the 2019 novel coronavirus","volume":"95","author":"Shah","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2021.02.002_bib3","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.mayocpiqo.2021.02.002_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ijid.2020.05.115","article-title":"Potential role of statins in COVID-19","volume":"96","author":"Lee","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2021.02.002_bib5","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.3390\/ijms21103544","article-title":"The role of lipid metabolism in COVID-19 virus infection and as a drug target","volume":"21","author":"Abu-Farha","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2021.02.002_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5114\/aoms.2020.94655","article-title":"Statins and the COVID-19 main protease: in silico evidence on direct interaction","volume":"16","author":"Reiner","year":"2020","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.mayocpiqo.2021.02.002_bib7","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.chest.2020.07.031","article-title":"Venous thromboembolism in COVID-19 ICU Patients","volume":"158","author":"Moll","year":"2020","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.02.002_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCULATIONAHA.112.145334","article-title":"Statins as antithrombotic drugs","volume":"127","author":"Violi","year":"2013","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.mayocpiqo.2021.02.002_bib9","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","article-title":"A\u00a0randomized trial of rosuvastatin in the prevention of venous thromboembolism","volume":"360","author":"Glynn","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mayocpiqo.2021.02.002_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jacl.2020.06.009","article-title":"Are statins safe in patients with COVID-19?","volume":"14","author":"Karalis","year":"2020","journal-title":"J\u00a0Clin Lipidol"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2021.02.002_bib11","doi-asserted-by":"crossref","first-page":"102569","DOI":"10.1016\/j.autrev.2020.102569","article-title":"Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: a comprehensive review","volume":"19","author":"Alijotas-Reig","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.mayocpiqo.2021.02.002_bib12","doi-asserted-by":"crossref","first-page":"e8086","DOI":"10.1371\/journal.pone.0008087","article-title":"Influenza morbidity and mortality in elderly patients receiving statins: a cohort study","volume":"4","author":"Kwong","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.02.002_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/jir695","article-title":"Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study","volume":"205","author":"Vandermeer","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"18","key":"10.1016\/j.mayocpiqo.2021.02.002_bib14","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","article-title":"Simvastatin in the acute respiratory distress syndrome","volume":"371","author":"McAuley","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2021.02.002_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomized controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2021.02.002_bib16","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1186\/cc11895","article-title":"Randomized double-blind placebo-controlled trial of 40 mg\/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)","volume":"16","author":"Patel","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.mayocpiqo.2021.02.002_bib17","doi-asserted-by":"crossref","first-page":"m1091","DOI":"10.1136\/bmj.m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.mayocpiqo.2021.02.002_bib18","doi-asserted-by":"crossref","first-page":"m1198","DOI":"10.1136\/bmj.m1198","article-title":"COVID-19: risk factors for severe disease and death","volume":"368","author":"Jordan","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2021.02.002_bib19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.cmi.2020.04.012","article-title":"Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2021.02.002_bib20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.amjmed.2020.03.041","article-title":"Inpatient care of patients with COVID-19: a guide for hospitalists","volume":"133","author":"Yetmar","year":"2020","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2021.02.002_bib21","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1213\/ANE.0000000000005292","article-title":"Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019","volume":"132","author":"Chow","year":"2021","journal-title":"Anesth Analg"},{"issue":"14","key":"10.1016\/j.mayocpiqo.2021.02.002_bib22","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s40265-020-01365-1","article-title":"Is acetylsalicylic acid a safe and potentially useful choice for adult patients with COVID-19?","volume":"80","author":"Bianconi","year":"2020","journal-title":"Drugs"},{"issue":"18","key":"10.1016\/j.mayocpiqo.2021.02.002_bib23","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/archinternmed.2009.286","article-title":"Statins for the Prevention and Treatment of Infections","volume":"169","author":"Tleyjeh","year":"2009","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.02.002_bib24","doi-asserted-by":"crossref","first-page":"e52929","DOI":"10.1371\/journal.pone.0052929","article-title":"The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis","volume":"8","author":"Khan","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2021.02.002_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cmi.2018.11.003","article-title":"Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults \u2014 a systematic review and meta-analysis","volume":"25","author":"Pertzov","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.02.002_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","article-title":"In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19","volume":"32","author":"Zhang","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.mayocpiqo.2021.02.002_bib27","article-title":"Effect of statin therapy on SARS-CoV-2 infection\u2013related mortality in hospitalized patients","author":"Masana","year":"2020","journal-title":"Eur Hear J Cardiovasc Pharmacother"},{"key":"10.1016\/j.mayocpiqo.2021.02.002_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjcard.2020.09.012","article-title":"Relation of statin use prior to admission to severity and recovery among COVID-19 inpatients","volume":"136","author":"Daniels","year":"2020","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2021.02.002_bib29","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11739-020-02504-y","article-title":"Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action","volume":"15","author":"Rossi","year":"2020","journal-title":"Intern Emerg Med"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2021.02.002_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/pathogens9090759","article-title":"Statin use is associated with decreased risk of invasive mechanical ventilation in COVID-19 patients: a preliminary study","volume":"9","author":"Song","year":"2020","journal-title":"Pathogens"},{"issue":"24","key":"10.1016\/j.mayocpiqo.2021.02.002_bib31","doi-asserted-by":"crossref","first-page":"e018475","DOI":"10.1161\/JAHA.120.018475","article-title":"Statin use and in-hospital mortality in patients with diabetes mellitus and COVID-19","volume":"9","author":"Saeed","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2021.02.002_bib32","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.dsx.2020.08.023","article-title":"Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection","volume":"14","author":"Hariyanto","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.02.002_bib33","doi-asserted-by":"crossref","first-page":"101202","DOI":"10.1016\/j.diabet.2020.10.001","article-title":"Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: results from the CORONADO study","volume":"47","author":"Cariou","year":"2020","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.02.002_bib34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13054-020-03154-4","article-title":"Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study","volume":"24","author":"Rodriguez-Nava","year":"2020","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2021.02.002_bib35","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jamda.2020.06.018","article-title":"The Effects of ARBs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents","volume":"21","author":"De Spiegeleer","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.02.002_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 \u2014 full report","volume":"9","author":"Jacobson","year":"2015","journal-title":"J\u00a0Clin Lipidol"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2021.02.002_bib37","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Chang","year":"2020","journal-title":"Cell Metab"},{"issue":"6515","key":"10.1016\/j.mayocpiqo.2021.02.002_bib38","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.mayocpiqo.2021.02.002_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/febs.15712","article-title":"Statins attenuate antiviral IFN-\u03b2 and ISG expression via inhibiting IRF3\/JAK\/STAT signaling in poly(I:C)-treated hyperlipidemic mice and macrophages","author":"Koike","year":"2021","journal-title":"FEBS J"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454821000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454821000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:10:11Z","timestamp":1762870211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454821000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2542454821000357"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.02.002","relation":{},"ISSN":["2542-4548"],"issn-type":[{"type":"print","value":"2542-4548"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Chronic Statin Use and 30-Day Mortality in Hospitalized Patients With COVID-19","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}]}}